Rethinking IgAN
Effects of Proteinuria Reduction on Delay of Kidney Failure in Patients With Immunoglobulin A Nephropathy
European Renal Association (ERA) Congress 2024
May 23 - 26, 2024
Stockholm
Unmet Needs in IgAN
Kidney Failure Attributed to Focal Segmental Glomerulosclerosis: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic Burden
Rate of Loss of eGFR and Time-Averaged Proteinuria in IgAN Patients Progressing From Early Stage Disease to Kidney Failure
Proteinuria and kidney survival in focal segmental glomerulosclerosis (FSGS) or immunoglobulin A nephropathy (IgAN): A NEPTUNE analysis
Predictors of Major Adverse Kidney Disease Events in a Real-World Population With IgA Nephropathy
The Humanistic Burden of Rare Kidney Diseases: Understanding the Impact of Focal Segmental Glomerulosclerosis (FSGS) and Immunoglobulin A Nephropathy (IgAN) on Patients and Caregivers Study (HONUS): Results for FSGS in the United States (US)
Clinicopathological Characteristics of Adult IgA Nephropathy in the United States
Long-Term Outcomes in IgA Nephropathy
Assessment of Health‐Related Quality of Life in Patients With Cystinuria on Tiopronin Therapy